Related Experiment Video
Updated: Jun 24, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors
Pelin Cengiz1, Kristy Seidel, Peter T Rycus
1Department of Pediatrics, University of Washington, Seattle, USA.
Insights
Pediatric patients requiring extracorporeal life support (ECLS) face a significant risk of central nervous system (CNS) complications. Pre-existing conditions like metabolic acidosis and use of certain devices increase this risk, necessitating close monitoring.
Area of Science:
- Pediatric Critical Care Medicine
- Cardiovascular Surgery
- Neurology
Background:
- Acute, severe central nervous system (CNS) complications are a serious concern in pediatric patients undergoing extracorporeal life support (ECLS).
- Understanding the incidence and risk factors is crucial for improving patient outcomes.
Purpose of the Study:
- To identify the incidence of acute, severe CNS complications in pediatric patients receiving ECLS.
- To determine the risk factors associated with the development of these CNS complications.
Main Methods:
- Retrospective review of the Extracorporeal Life Support Organization (ELSO) registry database.
- Analysis of data from 4,942 pediatric patients (1 month to 18 years) treated between 1981-2002 across 115 international tertiary centers.
Main Results:
- 12.9% of patients (636/4,942) developed acute, severe CNS complications.
- Risk factors identified include: ECLS during extracorporeal cardiopulmonary resuscitation (OR 2.48), pre-ECLS left ventricular assist device use (OR 3.45), bicarbonate administration (OR 1.61), and vasopressor/inotropic medications (OR 1.22).
- Venoarterial ECLS for pulmonary failure was associated with higher CNS complication rates compared to venovenous ECLS (13.5% vs 5.7%).
Conclusions:
- Patients with pre-ECLS metabolic acidosis, requirement for bicarbonate or inotropes/vasopressors, cardiopulmonary resuscitation, or a left ventricular assist device are at increased risk.
- Close monitoring for CNS complications is recommended for patients developing renal failure or metabolic acidosis post-ECLS, or those undergoing venoarterial ECLS.
Objective:
Identify the incidence and risk factors for development of acute, severe central nervous system (CNS) complications of pediatric extracorporeal life support (ECLS).
Design:
Retrospective review of Extracorporeal Life Support Organization (ELSO) registry database.
Setting:
Pediatric intensive care units of 115 tertiary centers internationally.
Patients:
Pediatric patients, 1 month to 18 yrs of age, who had ECLS between the years 1981-2002.
Measurements And Main Results:
Data concerning 4,942 patients who underwent one run of ECLS were analyzed. Six hundred thirty-six patients (12.9%) developed acute, severe CNS complications. Patients who required ECLS during extracorporeal cardiopulmonary resuscitation (n = 161; 3.3%) were more likely to develop CNS complications (n = 42; 26.1%) than patients who did not have extracorporeal cardiopulmonary resuscitation (p < .001; odds ratio [OR], 2.48; 95% confidence interval [CI], 1.73-3.57). Stepwise logistic regression analysis of therapies patients received before initiation of ECLS showed that the use of a left ventricular assist device (p = .001; OR, 3.45; 95% CI, 1.64-7.22), bicarbonate (p < .001; OR, 1.61; 95% CI, 1.26-2.05), and vasopressor/inotropic medications (p = .035; OR, 1.22; 95% CI, 1.01-1.48) were significant independent predictors of development of CNS complications. Among patients who had pulmonary failure as an indication for ECLS, the CNS complication rate was significantly higher for those treated with venoarterial ECLS than those who had venovenous ECLS (13.5% vs. 5.7%; p < .001; OR, 0.43; 95% CI, 0.34-0.67). Multiple logistic regression analysis of the complications other than CNS complications associated with the use of ECLS showed that pH <7.20, creatinine concentration >3.0 mg/dL, use of inotropes, presence of myocardial stun, and requirement of cardiopulmonary resuscitation during ECLS independently predicted development of CNS complications.
Conclusion:
Patients who have metabolic acidosis, a bicarbonate or inotrope/vasopressor requirement, cardiopulmonary resuscitation, or a left ventricular assist device before initiation of ECLS are at greater risk for development of CNS complications. After initiation of ECLS, patients who develop renal failure or metabolic acidosis or undergo venoarterial ECLS should be closely monitored for development of CNS complications.
Related Concept Videos
Acute Respiratory Failure-III
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

